Intersect ENT is a medical technology company dedicated to advancing the treatment of ear, nose, and throat (ENT) conditions through evidence-based innovation. We provide treatments for people with chronic sinusitis, an inflammatory sinus condition that has been shown to substantially reduce quality of life. Sinusitis is one of the most common conditions in the United States.
LOCALIZED STEROID-RELEASING TECHNOLOGY
Our core technology is our bioabsorbable drug release platform. The current portfolio of sinus implants is designed to provide mechanical support and localized drug delivery.